Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ingenium Pharmaceuticals AG

This article was originally published in Start Up

Executive Summary

Ingenium Pharmaceuticals AG is discovering drug targets through Deductive Genomics: observing gene function, or disease states, in mouse models and then reversing course to identify the responsible gene. By matching corresponding genes in the human genome, Ingenium hopes to accelerate drug discovery for immunology, neurobiology, metabolic diseases and cancer.

You may also be interested in...



CTG Pharma SRL

CTG Pharma SRL's founders believe that the unique properties of hydrogen sulfide (H2S) hold the key to exciting new anti-inflammatory therapeutics. The Italian start-up plans to tag already-approved compounds with an H2S-releasing molecule. The strategy has several potential advantages: it would create novel chemical entities, it would reduce the risks of drug development, and it could be applied with a variety of drugs.

GeneMedix's Big Biogeneric Gamble

Patent expiries in Europe on proteins such as EPO and interferon alpha may open up a huge market for cheaper versions of these proteins-one which GeneMedix and others are preparing to tap into. But it's a risky game, since there's still no regulatory process in Europe for approving such products.

Endocube SAS

Endocube, a French firm set up in 2001, aims to get at the genetic roots of inflammatory processes by investigating previously undescribed enzymes located on the surface of cuboidal cells--endothelial cells that have turned cube-like as a result of chronic inflammation.

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

SC090545

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel